The Nifty closed very close to the psychological level of 10,000 even as the cues coming in from the Dow and NASDAQ continued to be negative. Europe is still feeling the strain of the Italian issue. Asian markets have been buoyant on Monday led Read more [...]

News Announcement Impact Analysis World markets fell sharply as US and Europe touched multi-month lows US markets were hit by the potential outcome of a trade slowdown caused by the sanctions European Union has been trying hard to Read more [...]

Why are NBFCs in a rush to buy back their Commercial Paper At a time when the biggest risk in the market is the ability of NBFC’s to access funds, there is a different kind of story that is playing out in the market. In the last one week, three very Read more [...]

What went wrong with the Small Finance Bank stricture If you look at the price charts of two recent MFI listings (Ujjivan and Equitas), both stocks are quoting below their issue price. But the real price damage has happened after the recent RBI ruling. Read more [...]

Why are equities selling off across global markets When Fed hiked its rates in December 2015, it led to a massive sell-off in equities. From the lows of Feb 2016, the global market capitalization had grown from $60 trillion to nearly $100 trillion and Read more [...]

With the Dow down by 2.41% and the NASDAQ down by 4.67%, there was no way the Nifty was going to be in positive territory. Nifty reacted negatively to global cues on Thursday and opened weak and also failed to show any signs of recovery. Bharti corrected Read more [...]

After 3 days of correction, the Nifty finally had a positive respite on Wednesday. Nifty bounced 78 points to 10,225 levels on weak crude oil prices globally and a stronger rupee. With the Brent Crude losing $10/bbl from its peak levels, markets breathed Read more [...]

The negative trend on the Nifty continued for the 3rd successive day with the Nifty correcting below the 10,150 mark on negative global cues. Global cues continued to be negative as IT and pharma stocks were the worst hit. The worry over the trade war Read more [...]